Loading decisions…
Loading decisions…
4,996 vetted Board decisions in 2025.
The Board granted service connection for hypertension and valvular heart disease, but denied an increased rating for PTSD and granted an earlier effective date of February 25, 2013, for the grant of PTSD.
The Board denied the Veteran's claims for an initial compensable disability rating for insomnia disorder and a compensable disability rating for hypertension.
The Board remands the claims for service connection for sleep apnea, a left foot disability, a right foot disability, and hypertension to correct duty to assist errors that occurred prior to the April 2023 AOJ rating decision.
The Board granted service connection for prostate cancer and remanded the claims for cardiovascular disease and hypertension for a new VA medical opinion.
The Board denied an earlier effective date for the award of service connection for hypertension, as the Veteran did not submit a formal claim or informal communication indicating intent to apply for benefits prior to November 30, 2022.
The Board granted service connection for hypertension and right knee meniscal tear and medial collateral ligament tear with degenerative arthritis, but remanded the claims for a headache disorder and sleep apnea (OSA) due to inadequate medical opinions.
The Board denied the veteran's claims for increased ratings for his thoracolumbar spine, left and right shoulder disabilities, hypertension, and bilateral sensorineural hearing loss.
The Board granted a 10 percent rating for hypertension and service connection for chronic kidney disease as secondary to hypertension, while remanding other claims.
The Board denied the claim for service connection for a dental condition, to include tooth loss, and remanded claims for high blood pressure and leg/skin conditions due to insufficient evidence.
The Board granted an initial evaluation of 10 percent for hypertension, as the evidence supports a history of diastolic pressure predominantly 100 or more requiring continuous medication for control.
The Board granted service connection for bilateral hearing loss, tinnitus, and hypertension due to presumed exposure to Agent Orange. The claim for a prostate disability was remanded.
The Board remands the claims for an initial compensable rating for hypertension and service connection for bilateral peripheral vascular disease, to include as due to herbicide agent exposure and/or secondary to a service-connected disability.
The Board granted service connection for hypertension, finding that the Veteran's pre-existing condition was aggravated during his active-duty service. The claims for kidney stones and heart disease were remanded for further examination under the PACT Act.
The Board granted service connection for cervical spine degenerative disc disease and degenerative arthritis, right shoulder degenerative arthritis, left shoulder degenerative arthritis, and lumbosacral spine degenerative disc disease and degenerative arthritis. The claim for hypertension was denied.
The appeal was granted for service connection of a back disability, an effective date of April 24, 2023, for hypertension and post-traumatic headaches ratings, and TDIU. The claims for increased ratings were denied.
The Board denied the Veteran's claim for a compensable rating for hypertension as there was insufficient evidence to support that his diastolic pressure was predominantly 100 or more, or systolic pressure was predominantly 160 or more during the applicable appellate time period.
The Veteran's claim for a rating greater than 20 percent for hypertension and an earlier effective date prior to February 2, 2024 for the grant of an increased rating of 20 percent for hypertension was denied.
The Board denied all claims for increased ratings, except for sinusitis which was granted a higher rating.
The Board granted a 30 percent initial disability rating for service-connected kidney cancer and denied an increased rating greater than 30 percent. The claim for service connection for hypertension was remanded.
The Board granted earlier effective dates of May 19, 2011 for service connection for CAD, diabetes mellitus type II, and hypertension based on the Veteran's presumed exposure to herbicide agents during his service in Thailand.
← Back to Hypertension (high blood pressure) overview
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.